148 related articles for article (PubMed ID: 15005764)
1. Symptoms of persistent allergic rhinitis during a full calendar year in house dust mite-sensitive subjects.
Downie SR; Andersson M; Rimmer J; Leuppi JD; Xuan W; Akerlund A; Peat JK; Salome CM
Allergy; 2004 Apr; 59(4):406-14. PubMed ID: 15005764
[TBL] [Abstract][Full Text] [Related]
2. Association between nasal and bronchial symptoms in subjects with persistent allergic rhinitis.
Downie SR; Andersson M; Rimmer J; Leuppi JD; Xuan W; Akerlund A; Peat JK; Salome CM
Allergy; 2004 Mar; 59(3):320-6. PubMed ID: 14982515
[TBL] [Abstract][Full Text] [Related]
3. Eosinophils, specific hyperreactivity and occurrence of late phase reaction in allergic rhinitis.
Milanese M; Ricca V; Canonica GW; Ciprandi G
Eur Ann Allergy Clin Immunol; 2005 Jan; 37(1):7-10. PubMed ID: 15745370
[TBL] [Abstract][Full Text] [Related]
4. Absorption across the nasal airway mucosa in house dust mite perennial allergic rhinitis.
Greiff L; Andersson M; Svensson J; Wollmer P; Lundin S; Persson CG
Clin Physiol Funct Imaging; 2002 Jan; 22(1):55-7. PubMed ID: 12003101
[TBL] [Abstract][Full Text] [Related]
5. Comparison of conjunctival and nasal provocation test in allergic rhinitis to house dust mite.
Riechelmann H; Epple B; Gropper G
Int Arch Allergy Immunol; 2003 Jan; 130(1):51-9. PubMed ID: 12576735
[TBL] [Abstract][Full Text] [Related]
6. Nasal carriage of Staphylococcus aureus in house dust mite allergic patients and healthy controls.
Riechelmann H; Essig A; Deutschle T; Rau A; Rothermel B; Weschta M
Allergy; 2005 Nov; 60(11):1418-23. PubMed ID: 16197475
[TBL] [Abstract][Full Text] [Related]
7. Clinical evaluation of a double-blind dust-mite avoidance trial with mite-allergic rhinitic patients.
Kniest FM; Young E; Van Praag MC; Vos H; Kort HS; Koers WJ; De Maat-Bleeker F; Van Bronswijk JE
Clin Exp Allergy; 1991 Jan; 21(1):39-47. PubMed ID: 2021877
[TBL] [Abstract][Full Text] [Related]
8. Sublingual immunotherapy in children with allergic rhinoconjunctivitis mono-sensitized to house-dust-mites: a double-blind-placebo-controlled randomised trial.
Aydogan M; Eifan AO; Keles S; Akkoc T; Nursoy MA; Bahceciler NN; Barlan IB
Respir Med; 2013 Sep; 107(9):1322-9. PubMed ID: 23886432
[TBL] [Abstract][Full Text] [Related]
9. House dust mite avoidance measures for perennial allergic rhinitis.
Sheikh A; Hurwitz B
Cochrane Database Syst Rev; 2001; (4):CD001563. PubMed ID: 11687117
[TBL] [Abstract][Full Text] [Related]
10. [Efficacy and safety of sublingual immunotherapy with house dust mite extract in poly allergen sensitized children with allergic rhinitis].
Zhou L; Wang J; Chen Y; Luo R; Tao J; Nie M; Liu B; Li Y
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Oct; 26(20):913-6. PubMed ID: 23272490
[TBL] [Abstract][Full Text] [Related]
11. Sublingual immunotherapy in patients with house dust mite allergic rhinitis: prospective study of clinical outcomes over a two-year period.
Soh JY; Thalayasingam M; Ong S; Loo EX; Shek LP; Chao SS
J Laryngol Otol; 2016 Mar; 130(3):272-7. PubMed ID: 26781592
[TBL] [Abstract][Full Text] [Related]
12. Comparison of mometasone furoate monohydrate (Nasonex) and fluticasone propionate (Flixonase) nasal sprays in the treatment of dust mite-sensitive children with perennial allergic rhinitis.
Mak KK; Ku MS; Lu KH; Sun HL; Lue KH
Pediatr Neonatol; 2013 Aug; 54(4):239-45. PubMed ID: 23597528
[TBL] [Abstract][Full Text] [Related]
13. [The evaluation of hyposensitization with house dust in patients with nasal allergy to house dust-mite].
Ukai K; Amesara R; Masuda S; Nakamoto S; Ohkawa C; Okamoto K; Sakakura Y
Arerugi; 1994 Jan; 43(1):16-21. PubMed ID: 8147704
[TBL] [Abstract][Full Text] [Related]
14. Nasal hyperreactivity in allergic and non-allergic rhinitis: a potential risk factor for non-specific building-related illness.
Shusterman D; Murphy MA
Indoor Air; 2007 Aug; 17(4):328-33. PubMed ID: 17661929
[TBL] [Abstract][Full Text] [Related]
15. Nitric oxide metabolites in nasal lavage fluid of patients with house dust mite allergy.
Garrelds IM; van Amsterdam JG; de Graaf-in't Veld C; Gerth van Wijk R; Zijlstra FJ
Thorax; 1995 Mar; 50(3):275-9. PubMed ID: 7660342
[TBL] [Abstract][Full Text] [Related]
16. [Analysis of risk factors for deficits in the quality of life in allergic rhinitis patients].
Ogino T; Ishii H; Abe Y; Imada M; Hayashi T; Nonaka S; Harabuchi Y
Nihon Jibiinkoka Gakkai Kaiho; 2005 Jul; 108(7):715-23. PubMed ID: 16107046
[TBL] [Abstract][Full Text] [Related]
17. Allergic rhinitis due to house dust mites: evaluation of the efficacy of specific sublingual immunotherapy.
Tonnel AB; Scherpereel A; Douay B; Mellin B; Leprince D; Goldstein N; Delecluse P; Andre C
Allergy; 2004 May; 59(5):491-7. PubMed ID: 15080829
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of an intranasal house dust mite provocation model as a tool in clinical research.
Oldenbeuving NB; KleinJan A; Mulder PG; Lumley P; de Groot EJ; van Drunen CM; Fokkens WJ
Allergy; 2005 Jun; 60(6):751-9. PubMed ID: 15876304
[TBL] [Abstract][Full Text] [Related]
19. The effect of house dust mite specific immunotherapy on cysteinyl leukotriene production by blood leukocytes in subjects with perennial allergic rhinitis and asthma.
Saraçlar Y; Sekerel BE; Kalayci O; Adalioğlu G; Tuncer A
J Investig Allergol Clin Immunol; 1998; 8(2):98-104. PubMed ID: 9615303
[TBL] [Abstract][Full Text] [Related]
20. Measurement of inflammatory mediators of mast cells and eosinophils in native nasal lavage fluid in nasal polyposis.
Di Lorenzo G; Drago A; Esposito Pellitteri M; Candore G; Colombo A; Gervasi F; Pacor ML; Purello D'Ambrosio F; Caruso C
Int Arch Allergy Immunol; 2001 Jun; 125(2):164-75. PubMed ID: 11435734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
